尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

吴蕊; 董自平; 王胜奇; 秦俭

doi:10.3969/j.issn.1006-0111.2016.03.019

尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

doi: 10.3969/j.issn.1006-0111.2016.03.019

1.
首都医科大学宣武医院风湿免疫科, 北京 100053
2.
华北石油管理局总医院急诊科, 河北任丘 062552
3.
首都医科大学宣武医院急诊科, 北京 100053

Comparison of urapidil and nicardipine in the treatment of chronic renal failure patients with hypertensive emergencies

1.
Department of Rheumatology and Immunology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
2.
Department of Emergency, General Hospital of North China Petroleum Administration Bureau, Renqiu 062552, China
3.
Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

摘要: 目的比较尼卡地平和乌拉地尔治疗肾功能衰竭患者高血压急症的治疗效果和不良反应。方法 59例慢性肾功能衰竭高血压急症患者,将其随机分为尼卡地平组30例和乌拉地尔组29例:尼卡地平组先给予尼卡地平1 mg静推,随后以30~100 μg/min微量泵持续泵入,然后根据血压情况调整药物剂量;乌拉地尔组先给予乌拉地尔12.5 mg静推,然后以150~500 μg/min微量泵持续泵入,根据血压情况调整药物剂量。记录用药前后心率、血压情况及不良反应。结果两组治疗后的血压均较治疗前有明显下降(P<0.05),其中尼卡地平组在用药后1 h内降低收缩压的效果比乌拉地尔组更好(P<0.05),但随着治疗时间的延长(≥2 h),两组收缩压之间的差异逐渐缩小(P>0.05);而降低舒张压的效果两组之间的差异没有统计学意义(P>0.05)。乌拉地尔组用药后出现明显的心率减慢(P<0.05),而尼卡地平组心率明显加快(P<0.05)。两组不良反应率比较没有统计学意义(P>0.05)。结论尼卡地平和乌拉地尔对肾功能衰竭患者高血压急症均有良好的治疗效果,尼卡地平早期应用效果更佳。
- 尼卡地平 /
- 乌拉地尔 /
- 高血压急症 /
- 肾功能衰竭
Abstract: Objective To study the efficacies and adverse reactions of urapidil and nicardipine in the treatment of the chronic renal failure patients with hypertensive emergencies. Methods 59 chronic renal failure patients with hypertensive emergencies were randomly divided into nicardipine treatment group and urapidil treatment group. The patients in the nicardipine group were given a 1 mg nicardipine intravenous injection, and 30-100 μg/min intravenous transfusion was given continuously. The patients in the urapidil group were given a 12.5 mg urapidil intravenous injection, and 150-500 μg/min intravenous transfusion was given continuously. The dosage were changed according to the patients' blood pressure in both of the groups. The patients' blood pressure, heart rate and adverse reactions were recorded. Results The patients' blood pressure in both of the groups were significantly lower after treatment (P<0.05). The SBP in nicardipine treatment group was significant lower than SBP in urapidil treatment group in the first hour after treatment (P<0.05). There was no significant difference in SBP between the two groups 2 hours after treatment (P>0.05). There was no significant difference in DBP between the two groups after treatment (P>0.05). In the nicardipine group, the heart rate rose after the treatment, the difference was statistically significant (P<0.05).While in the urapidil group, the heart rate went down after the treatment, and the difference was statistically significant (P<0.05). There was no significant difference in adverse reactions between the two groups (P>0.05). Conclusion Both of nicardipine and urapidil were effective in the treatment of chronic renal failure patients with emergency hypertensive. Nicardipine was more effective in reducing the SBP in the first stage of treatment.
- nicardipine /
- urapidil /
- hypertension emergencies /
- chronic renal failure

[1]	中国高血压防治指南修订委员会. 中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2006.
[2]	孙菁, 周进祝. 内科学[M]. 8版. 北京:科学出版社, 2003:268.
[3]	张龙友, 刘易新, 于东明. 尼卡地平静脉注射治疗高血压急症25例临床观察[J]. 医学研究杂志, 2009, 38(10):57-59.
[4]	Denolle T, Sassano P, Allain H,et al. Effects of nicardipine and clonidine on cognitive functions and electroencephalograpy in hypertensive patients[J]. Fundam Clin Pharmacol, 2002, 16(6):527-535.
[5]	田国祥, 孟庆义. 高血压急症治疗.尼卡地平的兴起[J]. 中国循证心血管医学杂志, 2010, 2(1):6-8.
[6]	Suzuki S, Ohesuka S, Ishikawa K,et al. Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension[J]. Hypertens Res, 2003, 26(3):193-199.
[7]	王涛, 秦俭, 王晶, 等.尼卡地平和乌拉地尔治疗高血压急症的比较[J]. 现代生物医学进展, 2011, 11(21):4065-4067.
[8]	姜成菊, 邱家学, 徐韵, 等. 尼卡地平治疗高血压急症的Meta分析[J]. 中国药物应用与监测, 2013, 10(5):245-251.
[9]	宋尚明, 朱兴雷, 周生芬, 等. 乌拉地尔和尼卡地平治疗高血压急症的比较[J]. 中国新药与临床杂志,2005, 24(10):795-798.
[10]	刘学敏, 殷春阳. 乌拉地尔和尼卡地平治疗高血压急症的疗效比较[J]. 医药导报, 2012, 31(9):1158-1160.
[11]	谢云燕, 秦俭, 牛秋丽, 等. 乌拉地尔和尼卡地平对老年高血压急症的疗效及安全性比较[J]. 中华老年心脑血管病杂志, 2014, 4(16):370-373.

[1]	杨延涛, 郁超, 张志航, 潘宇炯, 何晓锋, 林敬宇, 李明智, 孙佳烨, 徐敏. 基于网络药理学、分子对接技术及体外实验验证探究健复饮治疗勃起功能障碍的作用机制 . 药学实践与服务, 2025, 43(): 1-10. doi: 10.12206/j.issn.2097-2024.202407013
[2]	郭静, 康金龙, 李强, 赵琳, 刘骥, 徐学武. 利多卡因不同给药途径对麻醉诱导气管插管心血管应激反应的抑制作用 . 药学实践与服务, 2025, 43(6): 303-306. doi: 10.12206/j.issn.2097-2024.202502009
[3]	郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛. 醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2025, 43(3): 136-142, 150. doi: 10.12206/j.issn.2097-2024.202310043
[4]	冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽. 菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(5): 228-234. doi: 10.12206/j.issn.2097-2024.202407038
[5]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[6]	王鹏, 张争艳, 吴宗贵. 活心丸（浓缩丸）联合八段锦对急性心肌梗死合并心力衰竭介入术预后的影响 . 药学实践与服务, 2025, 43(7): 348-352. doi: 10.12206/j.issn.2097-2024.202308034
[7]	李娜, 黄诚文, 孙秀娟, 王晓红, 张丽, 王兴坡. 奥希替尼与吉非替尼治疗表皮生长因子受体突变的晚期非小细胞肺癌的成本效果分析 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202411032
[8]	徐尧, 马春辉, 李志勇. 高血压对大鼠心血管纤维化及sFRP2表达的影响 . 药学实践与服务, 2025, 43(4): 180-184. doi: 10.12206/j.issn.2097-2024.202409055
[9]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 213-221. doi: 10.12206/j.issn.2097-2024.202412006
[10]	姜建芳, 王思平, 何新军. 硝苯地平在高血压孕妇中的药物毒性：基于FARES数据库的真实世界研究 . 药学实践与服务, 2025, 43(6): 307-312. doi: 10.12206/j.issn.2097-2024.202501001
[11]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(12): 512-519. doi: 10.12206/j.issn.2097-2024.202401050
[12]	王鹏, 陈顺, 赵逸, 高守红, 王志鹏. 卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
[13]	邹思, 吴岩斌, 吴锦忠, 吴建国, 黄家兴. 虎奶菇菌核多糖功能化纳米硒抗疲劳功效研究 . 药学实践与服务, 2024, 42(10): 426-432. doi: 10.12206/j.issn.2097-2024.202206072
[14]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[15]	凯丽比努尔·奥布力艾散, 李倩, 谢志, 贾文彦, 尹东锋. 星点设计-效应面法优化仑伐替尼混合胶束的制备工艺 . 药学实践与服务, 2024, 42(11): 495-502. doi: 10.12206/j.issn.2097-2024.202403019
[16]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050

点击查看大图

计量

文章访问数: 4841
HTML全文浏览量: 619
PDF下载量: 16
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

doi: 10.3969/j.issn.1006-0111.2016.03.019

Comparison of urapidil and nicardipine in the treatment of chronic renal failure patients with hypertensive emergencies

计量

尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

doi: 10.3969/j.issn.1006-0111.2016.03.019

1. 首都医科大学宣武医院风湿免疫科, 北京 100053

2. 华北石油管理局总医院急诊科, 河北任丘 062552

3. 首都医科大学宣武医院急诊科, 北京 100053

English Abstract

Comparison of urapidil and nicardipine in the treatment of chronic renal failure patients with hypertensive emergencies

全文HTML

目录

留言板

尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

doi: 10.3969/j.issn.1006-0111.2016.03.019

Comparison of urapidil and nicardipine in the treatment of chronic renal failure patients with hypertensive emergencies

计量

出版历程

尼卡地平和乌拉地尔治疗慢性肾功能衰竭高血压急症的比较

doi: 10.3969/j.issn.1006-0111.2016.03.019

1. 首都医科大学宣武医院风湿免疫科, 北京 100053 2. 华北石油管理局总医院急诊科, 河北 任丘 062552 3. 首都医科大学宣武医院急诊科, 北京 100053

English Abstract

Comparison of urapidil and nicardipine in the treatment of chronic renal failure patients with hypertensive emergencies

全文HTML

目录

1. 首都医科大学宣武医院风湿免疫科, 北京 100053

2. 华北石油管理局总医院急诊科, 河北任丘 062552

3. 首都医科大学宣武医院急诊科, 北京 100053